Ernest Prien, BS ’34 and Mary MacWilliam, EdD, UC Berkeley, 1956
The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.
Conan MacDougall, PharmD, MAS
Sepsis occurs when the body responds to an infection with a mix of tissue-damaging inflammation and anti-inflammatory responses. This biological storm can lead to acute organ dysfunction (severe sepsis) and dropping blood pressure that does not respond to intravenous fluids (septic shock).
Kevin Lance, a graduate student in the Desai lab, holds thin-film blood-vessel wrap being developed to deliver anti-scarring drugs.
Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.
I am a bioengineer focusing on micro and nanofabrication techniques to create new devices for drug and cell delivery as well as biomaterials for cell and tissue regeneration. I am the immediate past chair of seven years of the Department of Bioengineering and Therapeutic Sciences, a joint.
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:
Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.
Tejal Desai, PhD
Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube
Kathy Giacomini, PhD (center), co-chair of the Department of Bioengineering and Therapeutic Sciences, discusses research results in the lab with postdocs Sook Wah Yee (left), and Amber Dahlin (right).
Table of contents
Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
